673 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
LLY Eli Lilly and Company $105.71 $113.53B N/A
Article Searches
Company News for Jan 13, 2020 http://www.zacks.com/stock/news/715585/company-news-for-jan-13-2020?cid=CS-ZC--corporate_summary-715585 Jan 13, 2020 - Companies In The News Are: SNX, KBH, WDFC, LLY.
All the 2020 Pre-JPM News Healthcare Investors Need to Know https://www.fool.com/investing/2020/01/11/all-the-2020-pre-jpm-news-healthcare-investors-nee.aspx?source=iedfolrf0000001 Jan 11, 2020 - The Super Bowl of healthcare kicked off early for these companies.
Has Eli Lilly and (LLY) Outpaced Other Medical Stocks This Year? http://www.zacks.com/stock/news/711690/has-eli-lilly-and-lly-outpaced-other-medical-stocks-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-711690 Jan 10, 2020 - Is (LLY) Outperforming Other Medical Stocks This Year?
Benzinga Pro's Top 5 Stocks To Watch For Fri., Jan. 10, 2020: LLY, JPM, SRNE, ELAN, TWTR http://feeds.benzinga.com/~r/benzinga/~3/3IIihItXQgA/benzinga-pros-top-5-stocks-to-watch-for-fri-jan-10-2020-lly-jpm-srne-elan-twtr Jan 10, 2020 -

Benzinga Pro's Stocks To Watch For Friday

Eli Lilly (LLY) - Shares were quiet Friday morning despite news the company will purchase Dermira (DERM) for $18.75/share in cash. Dermira shares were up

read more

3 Pharma & Biotech Pipeline Areas to Keep an Eye on in 2020 http://www.zacks.com/stock/news/707821/3-pharma-biotech-pipeline-areas-to-keep-an-eye-on-in-2020?cid=CS-ZC-FT-analyst_blog|industry_focus-707821 Jan 08, 2020 - Here we present three non-cancer therapeutic areas wherein pipeline developments are expected to garner a lot of interest in 2020.
4 GARP Stocks to Scoop Up for Maximum Returns http://www.zacks.com/stock/news/704702/4-garp-stocks-to-scoop-up-for-maximum-returns?cid=CS-ZC-FT-analyst_blog|rw-704702 Jan 06, 2020 - If you're looking for a profitable portfolio of stocks that will offer the best of value and growth investing, try the growth at a reasonable price or GARP strategy.
A $20 Billion Sweet Spot in Biotech https://www.fool.com/investing/2019/12/28/a-20-billion-sweet-spot-in-biotech.aspx?source=iedfolrf0000001 Dec 28, 2019 - Few biotech companies ever reach that valuation, and if they do, you should snap them up for your portfolio.
Allergan (AGN) Gets FDA Approval for Migraine Drug Ubrelvy http://www.zacks.com/stock/news/685884/allergan-agn-gets-fda-approval-for-migraine-drug-ubrelvy?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-685884 Dec 24, 2019 - Allergan (AGN) gets FDA nod for Ubrelvy for the acute treatment of migraine with or without aura in adults.
Top Stock Reports for SAP, AbbVie & Sinopec http://www.zacks.com/research-daily/684233/top-stock-reports-for-sap-abbvie-sinopec?cid=CS-ZC-FT-research_daily-684233 Dec 23, 2019 - Top Stock Reports for SAP, AbbVie & Sinopec
Pharma Stock Roundup: Lilly's Upbeat 2020 Outlook, FDA Nod for PFE & MRK's Drugs http://www.zacks.com/stock/news/679924/pharma-stock-roundup-lillys-upbeat-2020-outlook-fda-nod-for-pfe-mrks-drugs?cid=CS-ZC-FT-analyst_blog|stock_roundup-679924 Dec 20, 2019 - Lilly (LLY) issues upbeat financial guidance for 2020. FDA approves label expansion of Pfizer's (PFE) Xtandi and Merck's (MRK) Ebola vaccine, Ervebo.

Pages: 1234567...68

<Page 2>